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Children more commonly present with protein energy malnutrition 
(PEM) at diagnosis of cancer in developing countries than in developed 
countries, depending on the type of cancer and extent of the disease.1-3 
PEM at cancer diagnosis is associated with delays in treatment, 
increased infections and a negative outcome.2 There is still controversy 
regarding the ideal criteria to use to describe PEM, as there are many 
methods and cut-off points.
Nutritional assessment and status at cancer 
diagnosis 
Nutritional assessment is the evaluation of the nutritional status 
of an individual or groups of individuals (population). It involves 
anthropometry, biochemical indicators, clinical examination and 
nutritional history.
Criteria for assessment of PEM
Anthropometry is the measurement of body weight and height, 
body composition and the comparison with different standards 
for corresponding age and gender groups in order to determine the 
nutritional status of an individual or population.4 
Height for age (H/A) of less than 95% of the median for age and 
gender indicates stunting (chronic malnutrition).5 Weight for age 
(W/A) under 90% of median indicates underweight5-7 and weight loss 
of more than 5% to pre-illness weight or in 1 month is regarded as 
serious.2,6,7 The body weight of children with cancer can be influenced 
by tumours, oedema or amputation of limbs,8 therefore weight alone is 
not sufficiently sensitive to identify malnutrition.3,5,9  Body mass index 
(BMI) for age and weight for height (W/H) under the 10th percentile 
indicate wasting (acute malnutrition).5,6  
Arm anthropometry involves measurements such as mid-upper arm 
circumference (MUAC) and triceps skinfold thickness (TSF) that are 
used to determine arm fat area (AFA) and arm muscle area (AMA), 
which indicate muscle and fat stores. TSF, AFA and AMA under the 
5th percentile indicates depleted fat and muscle stores.4,6 
A Z-score is a statistical measure of the difference between the value 
of the individual and the median of the reference value, expressed as a 
portion of the standard deviation (SD).10 A Z-score of <-2SD below the 
reference median of above is an indicator of severe malnutrition.6,7
Biochemical assessment measures nutrients in blood, faeces or urine 
– e.g. serum albumin under 3.2 mg/dl6,7 may be seen as an indicator of 
protein status.4 Careful interpretation is needed, because other non-
dietary factors are more often the reason for the decreased values. 
Clinical assessment includes a medical history and physical 
examination. Clinical signs of PEM include loss of subcutaneous fat and 
muscle, recent weight changes (not related to fluid retention or loss), 
oedema at ankles or sacrum and hair changes. Symptoms suggestive 
of vitamin and/or mineral deficiencies and medication-nutrient 
interactions are looked for.4 History of inability to chew and swallow, 
loss of appetite, vomiting, diarrhoea, constipation and gastrointestinal 
tract (GIT) dysfunction longer than 5 days are also signs of PEM.6 
Dietary assessment includes surveys of the quantity of foods consumed 
during the past 24 hours or past week.4 An intake of less than 70% of 
patient’s requirements for 5 days or more is seen as inadequate.6
Nutritional status of paediatric cancer patients at diagnosis 
The prevalence of malnutrition in paediatric cancer patients depends 
on the criteria used to identify the malnutrition, as shown by Sala et al.5 
PEM at diagnosis in children with cancer is estimated at 6 - 50%,1,6,5,11 
while  a Pretoria study indicated 25% of patients had PEM.10 
The authors compared different studies on children with cancer and 
found that there was no difference in W/H between children with 
cancer and the control group, but 23% of the patients had a TSF of 
≤2SD and 20% of the patients had a MUAC under the 5th percentile.5 
MUAC and TSF are not influenced by the tumour weight, so they must 
be used as part of the assessment of nutritional status in children with 
cancer, since they are more sensitive than weight alone.5,8 Furthermore, 
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according to Garófolo et al., malnutrition was 
observed in 40.2% of the patients with solid 
tumours in Brazil based on TSF, and 35.4% 
on MUAC, but only 18.9% based on W/H or 
BMI.8 In the Pretoria study malnutrition was 
found in 41.8% of patients based on MUAC 
and 32.8% on TSF compared with only 25% 
on H/A and 24.3% on W/A.10 
Effec t of malnutrition on 
paediatric cancer patients 
PEM in patients has a negative effect on the 
function of the GIT and immune system 
response to cancer treatment and on cancer 
outcome. 
Effect of PEM on the gastrointestinal 
tract
The effect of PEM on the GIT is explained in 
Fig. 1. The villi of the GIT tend to flatten,12 
decreasing the absorption area,13 leading to 
malabsorption or decreased absorption of 
nutrients.12 Villi are covered with cuboidal 
cells and fatty acids, causing lack of enzymes 
for digestion of nutrients. Lactase is one of the 
enzymes that can become deficient, resulting 
in malabsorption of glucose and lactose.  
PEM influences the normal function of 
the GIT, leading to decreased stomach 
acid, increased transit time and number of 
bacteria. The bacteria impair the formation 
of triglycerides (TG), phospholipids and 
micelles of bile salts that are needed for 
normal fat absorption, and these increase the 
risk for diarrhoea.12
Effect of PEM on the immune system
The immune system of children with 
PEM is compromised and they have a 
higher incidence of infection than well-
nourished children,7 as well as 20 times more 
complications.8 The walls of the GIT are 
thinner and micro-organisms can leak into 
the GIT walls (Fig. 1), leading to bacterial 
overgrowth that impairs immune function 
Fig.1. Effect of PEM on the gastrointestinal tract, compiled from literature.1,2,3,5,9,12,13 
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and leads to infections.13 A higher incidence 
of neutropenia,3 poor wound healing,13 
morbidity and mortality were also noted.12,13
Patients with leukaemia showed a significant 
association between poor nutritional status 
at diagnosis and rate of infection.3
Effect of PEM on response to cancer 
treatment
Malnourished patients respond poorly to 
medical interventions such as chemotherapy, 
radiotherapy and/or surgery,2 with increased 
episodes of toxicity from chemotherapy2,14 
and reduced drug metabolism.2
A decrease in tolerance to chemo-
therapy1,3,5,7,9,14 leads to reduced doses in 
future cycles.7 According to Sala et al.5 
malnourished patients only receive 50% of 
the doses of chemotherapy actually needed. 
This can lead to an impaired response to 
treatment13 and increased risk for treatment 
toxicity.1,11,14
Drug metabolism may be altered in 
malnourished patients,2,7 thiopurine 
methyltransferase activity may differ 
and fat stores may have an effect 
on pharmacokinetics.3 Methotrexate, 
5-fluorouracil, doxorubicin and penicillin 
have decreased clearance in under-nourished 
patients, suggesting decreased renal tubular 
secretions, an increased tumour response to 
chemotherapy and tubular damage.1
Effect of PEM on cancer outcome
The outcome in cancer can be seen as survival 
(disease free), relapse of disease or death.
Relapse of disease 
In developed countries undernutrition is 
resolved quickly and therefore not associated 
with relapse,3 but, untreated, can lead to 
cancer death.13 
Malnourished children on maintenance 
therapy receive half the dose of oral 
chemotherapy, causing relapse of disease.8 In 
patients with solid tumours, malnourished 
patients were more likely to relapse, especially 
those with neuroblastoma.6 
Death
PEM is a negative prognostic factor in patients 
and children with cancer,1,2,7,9 leading to as 
many as 20 - 25% of cancer deaths.13
Among 102 malnourished acute 
lymphoblastic leukaemia patients, 9.8% 
relapsed, 45% died and 46% were still 
alive compared with the well-nourished 
group, where only 19% died and 59% were 
still alive.15 A W/H of less than 80% of the 
expected median in 455 children with cancer 
had a significant negative effect on their 
survival.6 A study of paediatric oncology 
patients in Kalafong Hospital (Pretoria) 
indicated that children with depleted MUAC 
and AMA on admission had an increased 
risk of death.11
It is clear that PEM has a significant effect 
on treatment, and studies have shown an 
association between PEM at diagnosis and 
poor outcome in children with cancer.6,8,10,14
Nutritional status and 
intervention during cancer 
treatment 
The medical treatment of cancer has side-
effects that can lead to PEM, and nutritional 
support is important to prevent this 
becoming severe.
Side-effects of treatment
The medical treatment for cancer can 
cause taste alterations, anorexia, mucositis, 
dysphagia, reflux, early satiety, vomiting, 
diarrhoea, constipation or malabsorption. 
All these side-effects are worsened if there 
is lack of support by family and friends, and 
can lead to decreased oral intake, weight loss 
and eventually PEM.5
Development of PEM during 
treatment  
Children have decreased energy reserves 
compared with adults, and treatment can lead 
to deterioration of the nutritional status of the 
patient if nutritional intervention does not take 
place.1,9 PEM is caused by the increased energy 
expenditure due to tumour growth that uses 
the child’s body stores for fuel. GIT discomfort 
can occur because of enlarged organs pressing 
on the stomach. GIT toxicity and neutropenia 
can develop and cause bacterial sepsis, fever, 
neutropenic enterocolitis and pain. This 
decreases the ability of the body to absorb 
nutrients efficiently and leads to further 
nutritional depletion.11 
Sala et al.5 described Mexican children 
who were evaluated after 1 month’s 
chemotherapy and found that more than 
10% of the patients with high-risk disease 
had decreased muscle stores, compared 
with patients with low-risk disease. The 
Pretoria study indicated a worsening of 
patients’ degree of stunting, underweight 
and wasting but an improvement in TSF 
and MUAC after 3 months.10
Nutritional intervention  
The nutritional goals in a child with cancer are 
to maintain nutritional status,7 prevent PEM 
and poor growth and improve the quality 
of life. The best time to start nutritional 
intervention is at the time of diagnosis.13 It 
is important to remember that every child 
is unique and will tolerate cancer treatment 
differently. 
There are different types of nutritional 
intervention.
Oral intake
A high-energy high-protein diet can provide 
patients with sufficient energy to meet their 
nutritional needs and increase their physical 
performance and may also be used to try 
to increase their treatment tolerance and 
decrease therapy-related side-effects. 
Appropriate diets given to patients between 
chemotherapy cycles and before radiotherapy 
is started, increase their tolerance to 
treatment and improve their outcome.14  
Nutritional supplements 
Nutritional supplements are nutrient-dense 
beverages available in different flavours and 
packaging.
Sala et al.5 found that supplements alone 
were not effective in preventing malnutrition 
when given during treatment. The Pretoria 
study indicated an improvement in BMI, 
TSF, AMA and AFA after 3 months of 
supplementation.10
It is important to remember that patients 
with cachexia will not respond to nutritional 
supplementation alone13 and nutritional 
repletion cannot be achieved in a short 
period of time.
Nasogastric enteral feeds (NG)
NG feeds should be considered in paediatric 
cancer patients with PEM. It is also indicated 
in patients with 5% weight loss since the 
time of admission,9 a decrease in MUAC of 
10%,4 severe oral mucositis9 and when their 
oral intake is less than 60 - 80% of their 
nutritional requirements.1 
Enteral feeds are effective as the primary 
source of nutrients for children with 
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cancer.1 No complications were observed 
in neutropenic patients or patients with a 
low platelet count. The majority of children 
tolerated the tube feeds without complications1 
such as epistaxis, sinusitis, tube-related 
infections11 and vomiting or diarrhoea, even 
while receiving chemotherapy.1,9 
Continuous, constant infusion of NG feeds 
with a feeding pump is better tolerated than 
bolus feeds, and fewer complications occur. 
Nocturnal feeds are the best for children, 
because they can then lead a normal life and 
are not pressurised to eat adequately.9
Total parenteral nutrition (TPN)
TPN consists of the intravenous (IV) 
administration of nutrients to meet patients’ 
nutritional needs.  Indications are typhlitis, 
continuous vomiting, inability to access the 
GIT and diarrhoea. Supplementary TPN 
is given where oral intake is inadequate or 
requirements cannot be met by oral diet or 
enteral nutrition.1  
Patients with relapse of leukaemia/lymphoma 
received 90% of their RDA through TPN and 
have shown a decrease in malnutrition. W/H, 
TSF, albumin and transferrin concentrations 
normalised after 28 days.6 
Conclusion
All patients with cancer are at risk of 
malnutrition and deterioration in their 
nutritional status due to the effect of the 
chemotherapy and/or radiotherapy and this 
can increase the risk for a negative outcome. It 
is recommended that they undergo nutritional 
assessment on a regular basis and receive 
early and ongoing nutritional intervention to 
maintain their nutritional status. 
Different types of nutritional intervention 
can be used in the form of oral supplements, 
NG feeds and TPN that can maintain 
and improve a patient’s nutritional status. 
Nutritional intervention is a valid and 
inexpensive method to improve the outcome 
in cancer patients.
References available at www.cmej.org.za
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In a nutshell
•    Nutritional assessment is the evalu-
ation of the nutritional status of an 
individual or groups of individuals 
(population).
•    Protein energy malnutrition at cancer 
diagnosis is common in developing 
countries.
•    Malnutrition in patients has a negative 
effect on the function of the GIT.
•    Malnourished patients respond poorly 
to medical interventions.
•    Nutritional goals for paediatric oncol-
ogy patients are to prevent deteriora-
tion of the nutritional status and poor 
growth, and improve their quality of 
life.
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Gene switch the key to youthful brain
A genetic switch linked to memory impairment in elderly mice has been flipped back on, restoring their failing brains to a more youthful state. 
If a similar switch exists in people it may provide a way to keep human brains young.
To find out more about what underlies the cognitive decline that occurs with age, André Fischer of the European Neuroscience Institute in 
Göttingen, Germany, and colleagues analysed DNA from the brains of both young and old mice that had been set tasks involving learning and 
memory.
They found that when young mice are learning, a molecular fragment – an acetyl group – caps a particular site on the histone protein that DNA 
wraps itself around. The cap ends up close to a cluster of genes on the surrounding DNA that are involved in learning and which became more 
active during learning tasks.
By contrast, in older mice set the same tasks, the acetyl cap was missing and no boost in gene activity occurred during learning.
The team concludes that the acetyl cap acts as an on switch for the crucial genes. By injecting older mice with an enzyme that encourages the 
binding of acetyl groups, Fischer’s team were able to flip the switch on, which improved the mice’s learning and memory performance.
Unpublished post-mortem studies have linked acetyl caps to brain decline in humans. It’s not clear if flipping them would similarly improve 
brain function or how many switches control brain decline in humans.
New Scientist 15 May 2010.
